Therapeutic targets and new directions for antibodies developed for ovarian cancer. (2016)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/19420862.2016.1219005
PubMed Identifier: 27494775
Publication URI: http://europepmc.org/abstract/MED/27494775
Type: Journal Article/Review
Volume: 8
Parent Publication: mAbs
Issue: 8
ISSN: 1942-0862